Serum adipokines in inflammatory bowel disease

World Journal of Gastroenterology

Volumn 20, Issue 22, 2014, Pages 6912-6917

  Waluga, Marek ^a   Hartleb, Marek ^a   Boryczka, Grzegorz ^a   Kukla, Michał ^a   Zwirska Korczala, Krystyna ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Adipokines; Crohn's disease; Inflammatory bowel disease; Tumor growth factor 1; Ulcerative colitis

Indexed keywords

ADIPOCYTOKINE; AZATHIOPRINE; LEPTIN; MESALAZINE; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PREDNISONE; RESISTIN; ANTIINFLAMMATORY AGENT; CORTICOSTEROID; CYTOKINE; GASTROINTESTINAL AGENT; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE, HUMAN; RETN PROTEIN, HUMAN;

ADULT; ARTICLE; CLINICAL ARTICLE; COLONOSCOPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CROHN DISEASE; DRUG DOSE REDUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; ILEOCOLONOSCOPY; INFLAMMATORY BOWEL DISEASE; INTESTINE BIOPSY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; ULCERATIVE COLITIS; BIOPSY; BLOOD; CASE CONTROL STUDY; COLITIS, ULCERATIVE; DRUG COMBINATION; IMMUNOLOGY; MIDDLE AGED; TIME; TREATMENT OUTCOME; YOUNG ADULT;

ADIPOKINES; ADRENAL CORTEX HORMONES; ADULT; ANTI-INFLAMMATORY AGENTS; AZATHIOPRINE; BIOPSY; CASE-CONTROL STUDIES; COLITIS, ULCERATIVE; COLONOSCOPY; CROHN DISEASE; CYTOKINES; DRUG THERAPY, COMBINATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; LEPTIN; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; RESISTIN; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84902181681     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i22.6912     Document Type: Article

References (32)

1. Schäffler A, Schölmerich J, Büchler C. Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in intestinal and mesenteric diseases. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 103-111 [PMID: 16265128 DOI: 10.1038/ncpgasthep0090]
2. Maconi G, Greco S, Duca P, Ardizzone S, Massari A, Cassinotti A, Radice E, Porro GB. Prevalence and clinical significance of sonographic evidence of mesenteric fat alterations in Crohn's disease. Inflamm Bowel Dis 2008; 14: 1555-1561 [PMID: 18521926 DOI: 10.1002/ibd.20515]
3. Barbier M, Vidal H, Desreumaux P, Dubuquoy L, Bourreille A, Colombel JF, Cherbut C, Galmiche JP. Overexpression of leptin mRNA in mesenteric adipose tissue in inflammatory bowel diseases. Gastroenterol Clin Biol 2003; 27: 987-991 [PMID: 14732844]
4. Ahualli J. The fat halo sign. Radiology 2007; 242: 945-946 [PMID: 17325078 DOI: 10.1148/radiol.2423041600]
5. Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger H, Tilg H. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 2007; 178: 1748-1758 [PMID: 17237424]
6. Luk T, Malam Z, Marshall JC. Pre-B cell colony-enhancing factor (PBEF)/visfatin: a novel mediator of innate immunity. J Leukoc Biol 2008; 83: 804-816 [PMID: 18252866 DOI: 10.1189/jlb.0807581]
7. Tilg H, Moschen AR. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesityassociated diseases. Clin Sci (Lond) 2008; 114: 275-288 [PMID: 18194136 DOI: 10.1042/CS20070196]
8. Weigert J, Obermeier F, Neumeier M, Wanninger J, Filarsky M, Bauer S, Aslanidis C, Rogler G, Ott C, Schäffler A, Schölmerich J, Buechler C. Circulating levels of chemerin and adiponectin are higher in ulcerative colitis and chemerin is elevated in Crohn's disease. Inflamm Bowel Dis 2010; 16: 630-637 [PMID: 19714754 DOI: 10.1002/ibd.21091]
9. Valentini L, Wirth EK, Schweizer U, Hengstermann S, Schaper L, Koernicke T, Dietz E, Norman K, Buning C, Winklhofer-Roob BM, Lochs H, Ockenga J. Circulating adipokines and the protective effects of hyperinsulinemia in inflammatory bowel disease. Nutrition 2009; 25: 172-181 [PMID: 18849144 DOI: 10.1016/j.nut.2008.07.020]
10. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-753 [PMID: 16698746 DOI: 10.1136/gut.2005.082909]
11. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, Caprilli R, Colombel JF, Gasche C, Geboes K, Jewell DP, Karban A, Loftus EV, Peña AS, Riddell RH, Sachar DB, Schreiber S, Steinhart AH, Targan SR, Vermeire S, Warren BF. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 Suppl A: 5A-36A [PMID: 16151544]
12. Yamamoto K, Kiyohara T, Murayama Y, Kihara S, Okamoto Y, Funahashi T, Ito T, Nezu R, Tsutsui S, Miyagawa JI, Tamura S, Matsuzawa Y, Shimomura I, Shinomura Y. Production of adiponectin, an anti-inflammatory protein, in mesenteric adipose tissue in Crohn's disease. Gut 2005; 54: 789-796 [PMID: 15888786 DOI: 10.1136/gut.2004.046516]
13. Nishihara T, Matsuda M, Araki H, Oshima K, Kihara S, Funahashi T, Shimomura I. Effect of adiponectin on murine colitis induced by dextran sulfate sodium. Gastroenterology 2006; 131: 853-861 [PMID: 16952554 DOI: 10.1053/ j.gastro.2006.06.015]
14. Fayad R, Pini M, Sennello JA, Cabay RJ, Chan L, Xu A, Fantuzzi G. Adiponectin deficiency protects mice from chemically induced colonic inflammation. Gastroenterology 2007; 132: 601-614 [PMID: 17258715 DOI: 10.1053/j.gastro.2006.11.026]
15. Batra A, Zeitz M, Siegmund B. Adipokine signaling in inflammatory bowel disease. Inflamm Bowel Dis 2009; 15: 1897-1905 [PMID: 19408337 DOI: 10.1002/ibd.20937]
16. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem Biophys Res Commun 2004; 323: 630-635 [PMID: 15369797 DOI: 10.1016/ j.bbrc.2004.08.145]
17. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998; 394: 897-901 [PMID: 9732873 DOI: 10.1038/29795]
18. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, Bulkley GB, Bao C, Noble PW, Lane MD, Diehl AM. Leptin regulates proinflammatory immune responses. FASEB J 1998; 12: 57-65 [PMID: 9438411]
19. Karmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Voudouri T, Kouroumalis EA. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 100-105 [PMID: 16432373 DOI: 10.1097/01.MIB.0000200345.38837.46]
20. Franchimont D, Roland S, Gustot T, Quertinmont E, Toubouti Y, Gervy MC, Deviere J, Van Gossum A. Impact of infliximab on serum leptin levels in patients with Crohn' s disease. J Clin Endocrinol Metab 2005; 90: 3510-3516 [PMID: 15784704 DOI: 10.1210/jc.2004-1222]
21. Sitaraman S, Liu X, Charrier L, Gu LH, Ziegler TR, Gewirtz A, Merlin D. Colonic leptin: source of a novel proinflammatory cytokine involved in IBD. FASEB J 2004; 18: 696-698 [PMID: 14977884]
22. Cai Z, Zhang W, Li M, Yue Y, Yang F, Yu L, Cao X, Wang J. TGF-beta1 gene-modified, immature dendritic cells delay the development of inflammatory bowel disease by inducing CD4(+)Foxp3(+) regulatory T cells. Cell Mol Immunol 2010; 7: 35-43 [PMID: 20081874 DOI: 10.1038/cmi.2009.107]
23. Suenaert P, Maerten P, Van Assche G, Van Driessche W, Geboes K, Bulteel V, Simaels J, Augustijns P, Ceuppens JL, Rutgeerts P, Perrier C. Effects of T cell-induced colonic inflammation on epithelial barrier function. Inflamm Bowel Dis 2010; 16: 1322-1331 [PMID: 20155850 DOI: 10.1002/ ibd.21211]
24. Yoshimura T, Oppenheim JJ. Chemerin reveals its chimeric nature. J Exp Med 2008; 205: 2187-2190 [PMID: 18809717 DOI: 10.1084/jem.20081736]
25. Cash JL, Hart R, Russ A, Dixon JP, Colledge WH, Doran J, Hendrick AG, Carlton MB, Greaves DR. Synthetic chemerinderived peptides suppress inflammation through ChemR23. J Exp Med 2008; 205: 767-775 [PMID: 18391062 DOI: 10.1084/ jem.20071601]
26. Silswal N, Singh AK, Aruna B, Mukhopadhyay S, Ghosh S, Ehtesham NZ. Human resistin stimulates the pro-inflammatory cytokines TNF-alpha and IL-12 in macrophages by NF-kappaB-dependent pathway. Biochem Biophys Res Commun 2005; 334: 1092-1101 [PMID: 16039994 DOI: 10.1016/ j.bbrc.2005.06.202]
27. Paul G, Schäffler A, Neumeier M, Fürst A, Bataillle F, Buechler C, Müller-Ladner U, Schölmerich J, Rogler G, Herfarth H. Profiling adipocytokine secretion from creeping fat in Crohn's disease. Inflamm Bowel Dis 2006; 12: 471-477 [PMID: 16775490 DOI: 10.1097/00054725-200606000-00005]
28. Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, Macphee CH, Smith SA. Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 2003; 300: 472-476 [PMID: 12504108 DOI: 10.1016/S0006-291X(02)02841-3]
29. Kaser S, Kaser A, Sandhofer A, Ebenbichler CF, Tilg H, Patsch JR. Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro. Biochem Biophys Res Commun 2003; 309: 286-290 [PMID: 12951047 DOI: 10.1016/ j.bbrc.2003.07.003]
30. Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto K, Matsuki Y, Murakami M, Ichisaka T, Murakami H, Watanabe E, Takagi T, Akiyoshi M, Ohtsubo T, Kihara S, Yamashita S, Makishima M, Funahashi T, Yamanaka S, Hiramatsu R, Matsuzawa Y, Shimomura I. Visfatin: a protein secreted by visceral fat that mimics the effects of insulin. Science 2005; 307: 426-430 [PMID: 15604363 DOI: 10.1126/science.1097243]
31. Jia SH, Li Y, Parodo J, Kapus A, Fan L, Rotstein OD, Marshall JC. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 2004; 113: 1318-1327 [PMID: 15124023 DOI: 10.1172/JCI19930]
32. Moschen AR, Geiger S, Gerner R, Tilg H. Pre-B cell colony enhancing factor/NAMPT/visfatin and its role in inflammation-related bone disease. Mutat Res 2010; 690: 95-101 [PMID: 19583971 DOI: 10.1016/j.mrfmmm.2009.06.012]